Apellis Pharmaceuticals Common
(APLS)
|
9.2 |
$665M |
|
11M |
59.86 |
United Therapeutics Corp Common
(UTHR)
|
8.7 |
$629M |
|
2.9M |
219.89 |
Ascendis Pharma Sponsored ADR
(ASND)
|
6.5 |
$473M |
|
3.8M |
125.95 |
Argenx Se Sponsored ADR
(ARGX)
|
6.5 |
$470M |
|
1.2M |
380.43 |
Madrigal Pharmaceuticals Common
(MDGL)
|
6.0 |
$437M |
|
1.9M |
231.38 |
Sarepta Therapeutics Common
(SRPT)
|
5.8 |
$419M |
|
4.3M |
96.43 |
Biomarin Pharmaceutical Common
(BMRN)
|
5.7 |
$415M |
|
4.3M |
96.42 |
Spdr Series Trust - S&p Biotech Etf
(XBI)
|
5.5 |
$397M |
|
4.4M |
89.29 |
Amicus Therapeutics Common
(FOLD)
|
5.4 |
$389M |
|
27M |
14.19 |
Cerevel Therapeutics Hldng Common
(CERE)
|
4.4 |
$320M |
|
7.6M |
42.40 |
Krystal Biotech Common
(KRYS)
|
4.4 |
$318M |
|
2.6M |
124.06 |
Mirati Therapeutics Common
|
4.0 |
$287M |
|
4.9M |
58.75 |
Cymabay Therapeutics Common
|
3.6 |
$262M |
|
11M |
23.62 |
Xenon Pharmaceuticals Common
(XENE)
|
3.6 |
$261M |
|
5.7M |
46.06 |
Alnylam Pharmaceuticals Common
(ALNY)
|
2.9 |
$213M |
|
1.1M |
191.41 |
Intra-cellular Therapies Common
(ITCI)
|
2.2 |
$162M |
|
2.3M |
71.62 |
Moonlake Immunotherapeutics Class A Ord
(MLTX)
|
2.2 |
$156M |
|
2.6M |
60.39 |
Kymera Therapeutics Common
(KYMR)
|
1.3 |
$96M |
|
3.8M |
25.46 |
Structure Therapeutics Sponsored ADR
(GPCR)
|
1.3 |
$95M |
|
2.3M |
40.76 |
Syndax Pharmaceuticals Common
(SNDX)
|
1.3 |
$91M |
|
4.2M |
21.61 |
Biocryst Pharmaceuticals Common
(BCRX)
|
1.1 |
$78M |
|
13M |
5.99 |
Iovance Biotherapeutics Common
(IOVA)
|
0.8 |
$55M |
|
6.7M |
8.13 |
Roivant Sciences Common
(ROIV)
|
0.7 |
$52M |
|
4.7M |
11.23 |
Kura Oncology Common
(KURA)
|
0.6 |
$43M |
|
3.0M |
14.38 |
Spyre Therapeutics Common
(SYRE)
|
0.5 |
$40M |
|
1.8M |
21.52 |
Karuna Therapeutics Common
|
0.5 |
$40M |
|
125k |
316.51 |
Rocket Pharmaceuticals Common
(RCKT)
|
0.5 |
$38M |
|
1.3M |
29.97 |
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.5 |
$35M |
|
1.1M |
30.60 |
Marinus Pharmaceuticals Common
(MRNS)
|
0.5 |
$34M |
|
3.2M |
10.87 |
Mannkind Corp Common
(MNKD)
|
0.5 |
$33M |
|
9.0M |
3.64 |
Soleno Therapeutics Common
(SLNO)
|
0.4 |
$32M |
|
785k |
40.25 |
Verrica Pharmaceuticals Common
(VRCA)
|
0.4 |
$29M |
|
4.0M |
7.32 |
Immunogen Common
|
0.4 |
$26M |
|
875k |
29.65 |
Monte Rosa Therapeutics Common
(GLUE)
|
0.4 |
$26M |
|
4.5M |
5.65 |
Merus N V Common
(MRUS)
|
0.3 |
$24M |
|
889k |
27.50 |
Tourmaline Bio Common
(TRML)
|
0.3 |
$23M |
|
868k |
26.18 |
Avidity Biosciences Common
(RNA)
|
0.3 |
$23M |
|
2.5M |
9.05 |
Ultragenyx Pharmaceutical Common
(RARE)
|
0.2 |
$17M |
|
350k |
47.82 |
Fennec Pharmaceuticals Common
(FENC)
|
0.2 |
$14M |
|
1.2M |
11.22 |
Nuvalent Common
(NUVL)
|
0.2 |
$13M |
|
179k |
73.59 |
Taysha Gene Therapies Common
(TSHA)
|
0.1 |
$7.7M |
|
4.4M |
1.77 |
Aadi Biosciences Common
(AADI)
|
0.1 |
$5.8M |
|
2.8M |
2.02 |